WPD Pharmaceuticals Inc.
WBIO
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | 2.20K |
| Gross Profit | -- | -- | -- | -- | -2.20K |
| SG&A Expenses | 205.40K | 217.70K | 214.60K | 168.50K | 162.40K |
| Depreciation & Amortization | 8.10K | 8.70K | 6.70K | 4.70K | 7.20K |
| Other Operating Expenses | -- | -- | -- | -- | 2.40K |
| Total Operating Expenses | 213.40K | 226.40K | 221.30K | 173.20K | 174.20K |
| Operating Income | -213.40K | -226.40K | -221.30K | -173.20K | -174.20K |
| Income Before Tax | -6.00K | -104.80K | -149.40K | -60.60K | 4.39M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.01 | -0.10 | -0.15 | -0.06 | 4.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.00K | -104.80K | -149.40K | -60.60K | 4.39M |
| EBIT | -213.40K | -226.40K | -221.30K | -173.20K | -174.20K |
| EBITDA | -207.40K | -221.50K | -214.90K | -165.40K | -166.20K |
| EPS Basic | 0.00 | -0.02 | -0.03 | -0.01 | 0.97 |
| Normalized Basic EPS | -0.04 | -0.04 | -0.04 | -0.03 | 0.15 |
| EPS Diluted | 0.00 | -0.02 | -0.03 | -0.01 | 0.97 |
| Normalized Diluted EPS | -0.04 | -0.04 | -0.04 | -0.03 | 0.15 |
| Average Basic Shares Outstanding | 18.25M | 18.16M | 18.15M | 18.15M | 18.15M |
| Average Diluted Shares Outstanding | 18.25M | 18.16M | 18.15M | 18.15M | 18.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
